Buy Emcure Pharma; target of Rs 2260: Motilal Oswal

Motilal Oswal issued a buy rating for Emcure Pharma with a target price of Rs 2260.

The recommendation is based on a research report dated July 20, 2026.

The report is bullish on the stock.